Generic and innovator drugs a guide to FDA approval requirements
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Austin, Tex.
Wolters Kluwer Law & Business
c2008-
|
| Ausgabe: | 7. ed. |
| Schlagworte: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nam a2200000 ca4500 | ||
|---|---|---|---|
| 001 | BV039635900 | ||
| 003 | DE-604 | ||
| 005 | 20111209 | ||
| 007 | t | ||
| 008 | 111013m2008uuuu |||| 00||| eng d | ||
| 020 | |a 9780735576636 |9 978-0-7355-7663-6 | ||
| 020 | |a 0735576637 |9 0-7355-7663-7 | ||
| 035 | |a (OCoLC)227182835 | ||
| 035 | |a (DE-599)BVBBV035782640 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Beers, Donald O. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Generic and innovator drugs |b a guide to FDA approval requirements |c Donald O. Beers |
| 250 | |a 7. ed. | ||
| 264 | 1 | |a Austin, Tex. |b Wolters Kluwer Law & Business |c c2008- | |
| 300 | |a Losebl.-Ausg. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Includes index | ||
| 650 | 4 | |a Drugs / Generic substitution / Law and legislation / United States | |
| 650 | 4 | |a Drugs / United States / Generic substitution / Patents | |
| 650 | 4 | |a Patent extensions / United States | |
| 650 | 4 | |a Recht | |
| 651 | 4 | |a USA | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-024485924 | ||
Datensatz im Suchindex
| _version_ | 1804148488449032193 |
|---|---|
| any_adam_object | |
| author | Beers, Donald O. |
| author_facet | Beers, Donald O. |
| author_role | aut |
| author_sort | Beers, Donald O. |
| author_variant | d o b do dob |
| building | Verbundindex |
| bvnumber | BV039635900 |
| ctrlnum | (OCoLC)227182835 (DE-599)BVBBV035782640 |
| edition | 7. ed. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01073nam a2200337 ca4500</leader><controlfield tag="001">BV039635900</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20111209 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">111013m2008uuuu |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780735576636</subfield><subfield code="9">978-0-7355-7663-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0735576637</subfield><subfield code="9">0-7355-7663-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)227182835</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV035782640</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Beers, Donald O.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Generic and innovator drugs</subfield><subfield code="b">a guide to FDA approval requirements</subfield><subfield code="c">Donald O. Beers</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">7. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Austin, Tex.</subfield><subfield code="b">Wolters Kluwer Law & Business</subfield><subfield code="c">c2008-</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Losebl.-Ausg.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / Generic substitution / Law and legislation / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / United States / Generic substitution / Patents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Patent extensions / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Recht</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-024485924</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV039635900 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T00:07:56Z |
| institution | BVB |
| isbn | 9780735576636 0735576637 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-024485924 |
| oclc_num | 227182835 |
| open_access_boolean | |
| physical | Losebl.-Ausg. |
| publishDate | 2008 |
| publishDateSearch | 2008 |
| publishDateSort | 2008 |
| publisher | Wolters Kluwer Law & Business |
| record_format | marc |
| spelling | Beers, Donald O. Verfasser aut Generic and innovator drugs a guide to FDA approval requirements Donald O. Beers 7. ed. Austin, Tex. Wolters Kluwer Law & Business c2008- Losebl.-Ausg. txt rdacontent n rdamedia nc rdacarrier Includes index Drugs / Generic substitution / Law and legislation / United States Drugs / United States / Generic substitution / Patents Patent extensions / United States Recht USA |
| spellingShingle | Beers, Donald O. Generic and innovator drugs a guide to FDA approval requirements Drugs / Generic substitution / Law and legislation / United States Drugs / United States / Generic substitution / Patents Patent extensions / United States Recht |
| title | Generic and innovator drugs a guide to FDA approval requirements |
| title_auth | Generic and innovator drugs a guide to FDA approval requirements |
| title_exact_search | Generic and innovator drugs a guide to FDA approval requirements |
| title_full | Generic and innovator drugs a guide to FDA approval requirements Donald O. Beers |
| title_fullStr | Generic and innovator drugs a guide to FDA approval requirements Donald O. Beers |
| title_full_unstemmed | Generic and innovator drugs a guide to FDA approval requirements Donald O. Beers |
| title_short | Generic and innovator drugs |
| title_sort | generic and innovator drugs a guide to fda approval requirements |
| title_sub | a guide to FDA approval requirements |
| topic | Drugs / Generic substitution / Law and legislation / United States Drugs / United States / Generic substitution / Patents Patent extensions / United States Recht |
| topic_facet | Drugs / Generic substitution / Law and legislation / United States Drugs / United States / Generic substitution / Patents Patent extensions / United States Recht USA |
| work_keys_str_mv | AT beersdonaldo genericandinnovatordrugsaguidetofdaapprovalrequirements |